Background A 50-year-old woman presented with recurrent episodes of unstable angina pectoris refractory to vasodilator treatment. Relevant coronary stenoses were excluded by coronary angiography and ...

The ASSOCIATE study investigators have reported that the I f current inhibitor, ivabradine, is safe, improves exercise performance, and delays the development of ischemia in patients with chronic ...

reduction of symptom severity of the angina attacks reduction of frequency of attacks improving the underlying pathology to improve blood flow to the heart muscles The third target aims at reducing ...

Calgary, Alberta--(Newsfile Corp. - September 16, 2025) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ ...

PHOENIX, AZ — Cardiologists commonly fail to recognize that an outpatient with stable CAD has had recent chest pain, so they do not escalate angina treatment, a study of more than 1000 outpatients ...

Chronic angina is a major medical problem in the United States with more than 6 million patients affected, a number that will increase substantially because of the progressive aging of the population.

A new antiangina treatment will be distributed to pharmacies at the end of March. Ranolazine (Ranexa, CV Therapeutics) has antianginal and antiischemic effects that do not depend on reductions in ...

Angina is a type of chest pain produced by a decrease in blood flow to the heart. Angina is mostly an indication of coronary artery disease. Angina, commonly known as angina pectoris, produces ...

VANCOUVER, - Neovasc Inc., a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment ...